| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Institut du Cancer de Montréal, Centre Hospitalier Notre-Dame, and Département de Biochimie, Université de Montréal, Montréal, Quebec, Canada
A comparison between the levels of ribonuclease inhibitor in normal rat liver and Novikoff hepatoma 105,000 x g supernatant fractions is reported. Novikoff hepatoma contained 61% less inhibitor per g of tissue or 39% less per mg protein than did normal rat liver.
A rapid and simple method that had been developed for the purification of rat liver ribonuclease inhibitor was applied to Novikoff hepatoma 105,000 x g supernatant fraction. The purification procedure led to a 121-fold increase in specific activity, with a yield of 49%. The molecular weight and inhibition curve of purified inhibitor were also determined and were found to be similar to those of normal rat liver ribonuclease inhibitor.
1 This investigation was supported by grants from the National Cancer Institute of Canada, Le Ministère des Affaires Sociales du Québec, La Fondation J. H. Biermans, and Les Fondations J. Rhéaume.
2 Recipient of a studentship from l'Institut du Cancer de Montréal.
3 Recipient of a studentship from the Medical Research Council of Canada.
4 Research Associate of the National Cancer Institute of Canada.
Received 3/18/74. Accepted 6/ 5/74.
This article has been cited by other articles:
![]() |
M. C. Haigis, E. L. Kurten, and R. T. Raines Ribonuclease inhibitor as an intracellular sentry Nucleic Acids Res., February 1, 2003; 31(3): 1024 - 1032. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |